SCHEMBL3566012

SCHEMBL3566012

CCCCC1(NCCc2ccccc2)CCC(=O)CC1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.44
TAAR1 Q96RJ0 3/20 0.39
PKM P14618 1/20 0.39
MAPK1 P28482 1/20 0.39
HPGD P15428 1/20 0.39
HDAC3 O15379 1/20 0.38
CNR2 P34972 2/20 0.38
CNR1 P21554 1/20 0.38
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
ATM Q13315 1/20 0.37
KDM4E B2RXH2 1/20 0.36
KCNH2 Q12809 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35
MMP13 P45452 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3572319 0.81 HSD17B10 (0.31)
SCHEMBL3571850 0.77 MEN1 (0.39) PKMMEN1KMT2AKDM4EMMP2
SCHEMBL28532777 0.71 SIGMAR1 (0.46) SIGMAR1TAAR1HPGDHDAC3ATM
SCHEMBL7618070 0.69 ALDH1A1 (0.40) TAAR1PKMHPGDMEN1KMT2A
SCHEMBL20376110 0.69 RAB9A (0.39) SIGMAR1TAAR1HPGDKMT2ARAB9A
SCHEMBL3566010 0.69 OPRM1 (0.46) MEN1KMT2AMMP2MMP9MMP8
SCHEMBL10509430 0.68 MMP2 (0.43) PKMCNR1MEN1KMT2ANPC1
SCHEMBL1303916 0.66 OPRM1 (0.44) TAAR1MEN1KMT2A
SCHEMBL3218332 0.66 HTT (0.36) TAAR1HDAC3MEN1KMT2AKDM4E
SCHEMBL8023946 0.65 OPRM1 (0.54) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101622255-B Spirocyclic cyclohexane derivatives GRUENENTHAL GMBH 2013-12-11 CN disclosed
EP-2121689-B1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES GRUENENTHAL GMBH (DE) 2013-07-31 EP disclosed
US-8404740-B2 Spirocyclic cyclohexane compounds GRUENENTHAL GMBH (DE) 2013-03-26 US disclosed
US-20100048554-A1 Spirocyclic Cyclohexane Compounds GRUENENTHAL GMBH (DE) 2010-02-25 US disclosed
CN-101622255-A Spirocyclic cyclohexane derivatives GRUENENTHAL GMBH 2010-01-06 CN disclosed
EP-2121689-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2009-11-25 EP disclosed
WO-2008101659-A1 SPIROCYCLIC CYCLOHEXANE DERIVATIVES Grünenthal GmbH (DE) 2008-08-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048554-A1 Spirocyclic Cyclohexane Compounds OPRL1, OPRD1, OPRK1 SIGMAR1 8/4885TAAR1 177/4885PKM 3428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.